Klaviyo upgraded to Overweight from Equal Weight at Barclays

Barclays upgraded Klaviyo to Overweight from Equal Weight with a price target of $29, up from $25. The analyst says Klaviyo “sticks out as a top growth asset that has not been properly rewarded for its healthy execution. The company is resilient given its data model and many avenues for growth, despite small business fears, the analyst tells investors in a research note. The firm sees a path for solid beats going forward and believes the stock is “at finally the right price.”